KRAS-mutant pancreatic cancer, KRAS-driven lung carcinomas, and KRAS-altered colorectal cancers all provide distinct problems and chances for intervention due to their invasive nature, resilience, and complexity. The gene discussed is KRAS; the disease is colorectal cancer.